Literature DB >> 10680017

Gene transfer facilitated by a cellular targeting molecule, reovirus protein sigma1.

Y Wu1, M J Boysun, K L Csencsits, D W Pascual.   

Abstract

To facilitate eventual genetic vaccination of mucosal tissues, a receptor-mediated gene transfer system was devised using the reovirus adhesin, protein sigma1. Highly efficient uptake and internalization of protein sigma1 polylysine (PL) DNA complexes could be demonstrated by fluorescent microscopy. Successful cellular transfection of rodent and human cell lines was obtained with the recombinant protein sigma1 as a PL-DNA complex, and could be shown to be receptor-specific. Transfection efficiency was dependent upon the ratio of DNA complexed to protein sigma1-PL and chloroquine treatment improved transfection efficiency dramatically. To test its ability to bind a mucosal inductive tissue, recombinant protein sigma1 was specifically bound to the nasal-associated lymphoid tissues (NALT). Thus, recombinant protein sigma1-PL-DNA conjugates can efficiently bind and transfect cells that express the receptor for protein sigma1. Gene Therapy (2000) 7, 61-69.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680017     DOI: 10.1038/sj.gt.3301046

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  M cell-targeted mucosal vaccine strategies.

Authors:  M Yamamoto; D W Pascual; H Kiyono
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 3.  Novel vaccine development strategies for inducing mucosal immunity.

Authors:  Yoshiko Fujkuyama; Daisuke Tokuhara; Kosuke Kataoka; Rebekah S Gilbert; Jerry R McGhee; Yoshikazu Yuki; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Expert Rev Vaccines       Date:  2012-03       Impact factor: 5.217

4.  M cell-targeted DNA vaccination.

Authors:  Y Wu; X Wang; K L Csencsits; A Haddad; N Walters; D W Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 5.  Intestinal Uptake and Tolerance to Food Antigens.

Authors:  Yuhong Xiong; Guifeng Xu; Mingwu Chen; Hongdi Ma
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

6.  Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.

Authors:  Hideaki Suzuki; Shinichi Sekine; Kosuke Kataoka; David W Pascual; Massimo Maddaloni; Ryoki Kobayashi; Keiko Fujihashi; Haruo Kozono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

7.  Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.

Authors:  Agnieszka Rynda; Massimo Maddaloni; Dagmara Mierzejewska; Javier Ochoa-Repáraz; Tomasz Maslanka; Kathryn Crist; Carol Riccardi; Beata Barszczewska; Kohtaro Fujihashi; Jerry R McGhee; David W Pascual
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.